GSK Settles Zantac Lawsuit Set for Trial in California (Correct)

GSK Plc reached a settlement for another US lawsuit claiming the drugmaker’s blockbuster heartburn medication Zantac causes cancer.

The UK pharmaceutical company didn’t disclose the value of the settlement in a statement Wednesday. The case, which was scheduled to begin trial in California state court on Nov. 13, will be dismissed, it said. GSK shares rose as much as 2.3% in early London trading before paring gains.

A number of former Zantac users have sued GSK after the drug was found in 2019 to contain a probable carcinogen called NDMA. The US Food and Drug Administration forced Zantac and ...